This inventor holds 2 USPTO granted patents. Top assignee: Aktiebolaget Hassle. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Minoru Oda: Innovator in Pharmaceutical Formulations
Introduction
Minoru Oda is a notable inventor based in Ohita, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on acid labile substances for oral use. With a total of 2 patents, Oda's work has implications for the treatment of gastrointestinal diseases.
Latest Patents
Oda's latest patents include innovative pharmaceutical preparations. The first patent details a formulation containing an acid labile compound combined with an alkaline reacting compound or an alkaline salt. This preparation also includes subcoating layers of inert compounds that are soluble in water, along with an enteric coating. This formulation aims to enhance the treatment of gastrointestinal diseases. The second patent focuses on a pharmaceutical preparation containing omeprazole, which is also combined with an alkaline reacting compound. Similar to the first patent, it includes subcoating layers and an enteric coating, designed for effective oral use in treating gastrointestinal conditions.
Career Highlights
Minoru Oda is associated with Aktiebolaget Hassle, where he has contributed to the development of advanced pharmaceutical products. His expertise in formulating effective medications has positioned him as a key player in the pharmaceutical industry.
Collaborations
Oda has collaborated with notable professionals in his field, including Kurt I Lovgren and Ake G Pilbrant. These collaborations have further enriched his research and development efforts.
Conclusion
Minoru Oda's innovative work in pharmaceutical formulations demonstrates his commitment to improving healthcare solutions. His patents reflect a deep understanding of the complexities involved in drug formulation, particularly for gastrointestinal treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
